Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of dapsone in subjects with acne vulgaris following 28 days of dosing.
Epistemonikos ID: f014e5cf519a5437663f8fef09006bd9e8cfdef2
First added on: May 11, 2024